PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, Ohio, USA.\', \'Department of Cardiovascular Medicine, Toho University Faculty of Medicine, Ota-ku, Japan.\', \'Department of Cardiovascular Medicine, Toho University Graduate School of Medicine, Ota-ku, Japan.\', \'Department of Cardiovascular Medicine, Kobe City Medical Center General Hospital, Kobe, Japan.\', \'Department of Cardiovascular Medicine, Tokyo Medical and Dental University, Bunkyo-ku, Japan.\', \'Department of Cardiology, Keio University School of Medicine, Shinjuku-ku, Japan.\', \'Department of Cardiology, Tokai University School of Medicine, Isehara, Japan.\', \'Department of Graduate School of Medicine (Cardiology), International University of Health and Welfare, Fukuoka, Japan.\', \'Department of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo, Bunkyo-ku, Japan.\', \'Division of Cardiovascular Medicine, Kobe University Graduate School of Medicine, Kobe, Japan.\', \'Department of Cardiovascular Medicine, Saga University, Saga, Japan.\', \'Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine, Bunkyo-ku, Japan yuya8950@gmail.com.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1136/bmjopen-2021-052708
?:doi
?:hasPublicationType
?:journal
  • BMJ open
is ?:pmid of
?:pmid
?:pmid
  • 34497086
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.372
?:rankingScore_hIndex
  • 57
?:title
  • External validation of the 4C Mortality Score for patients with COVID-19 and pre-existing cardiovascular diseases/risk factors.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all